Aakaar Medical Technologies IPO 2025: Complete Investment Guide

The Aakaar Medical Technologies IPO is creating significant buzz in the Indian stock market as one of the most anticipated IPO launches of June 2025. This aesthetic medical company is preparing to go public with a fresh issue worth ₹27 crores, targeting investors interested in the rapidly growing cosmetic and medical device sector.

Are you wondering whether the Aakaar Medical Technologies IPO is worth your investment? With the subscription opening on June 20, 2025, time is running out to make an informed decision. This comprehensive guide will provide you with everything you need to know about this IPO – from pricing details to financial analysis and investment recommendations.

Let’s dive deep into what makes this IPO tick and whether it deserves a place in your investment portfolio.

What is Aakaar Medical Technologies Limited?

Aakaar Medical Technologies Limited is a specialized aesthetic medical company incorporated in June 2013. The company has established itself as a significant player in India’s cosmetic and medical device industry, serving a diverse clientele of dermatologists, plastic surgeons, aesthetic physicians, and cosmetologists.

Core Business Operations

The company operates through a comprehensive business model that includes:

  • Manufacturing and Distribution: Both domestic manufacturing and international sourcing
  • Product Portfolio: Specialized cosmetic products and advanced medical devices
  • Geographic Reach: Pan-India presence through trained sales and service engineers
  • Target Market: Healthcare professionals in the aesthetic medicine sector

Product Range and Offerings

Aakaar Medical Technologies offers an extensive range of products across multiple categories:

Professional Medical Equipment

  • Tattoo removal devices
  • Pigmentation treatment equipment
  • Skin rejuvenation devices
  • Laser hair reduction systems
  • Hair transplant devices
  • Urinary incontinence treatment devices

Skincare and Cosmetic Products

  • Professional skincare products
  • Homecare skincare solutions
  • Injectable and contouring products
  • Hair growth serums and tablets
  • Anti-hair loss solutions
  • Medifacial kits

The company sources products from multiple international markets including South Korea, Spain, Italy, and Austria, ensuring access to cutting-edge technology and high-quality products.

Aakaar Medical Technologies IPO Details

Key IPO Information

ParameterDetails
IPO Size₹27.00 Crores
Issue TypeBook Building (Fresh Issue Only)
Total Shares37,50,400 shares
Face Value₹10 per share
Price Band₹68 to ₹72 per share
Lot Size1,600 shares
Listing ExchangeNSE SME

Important Dates and Timeline

The Aakaar Medical Technologies IPO follows a tight schedule that investors must be aware of:

EventDate
IPO Opening DateFriday, June 20, 2025
IPO Closing DateTuesday, June 24, 2025
Allotment DateWednesday, June 25, 2025
Refund InitiationThursday, June 26, 2025
Credit to DematThursday, June 26, 2025
Listing DateFriday, June 27, 2025
UPI Mandate Cut-off5 PM on June 24, 2025

Investment Requirements

Understanding the minimum investment requirements is crucial for different investor categories:

For Retail Investors

  • Minimum Investment: ₹1,08,800 (at lower price band)
  • Recommended Investment: ₹1,15,200 (at cut-off price)
  • Maximum Lots: 1 lot only
  • Total Shares: 1,600 shares

For HNI (High Net Worth Individuals)

  • Minimum Investment: ₹2,30,400
  • Minimum Lots: 2 lots
  • Total Shares: 3,200 shares

Share Allocation and Reservation

The Aakaar Medical Technologies IPO follows standard SME IPO allocation norms:

Investor CategoryAllocation
QIB (Qualified Institutional Buyers)Not more than 50% of Net Issue
Retail InvestorsNot less than 35% of Net Issue
NII (Non-Institutional Investors/HNI)Not less than 15% of Net Issue

Market Maker Allocation

  • Market Maker: Alacrity Securities Ltd.
  • Reserved Shares: 1,88,800 shares

Financial Performance Analysis

Revenue and Profitability Trends

The Aakaar Medical Technologies financial performance shows impressive growth trajectory:

Financial YearFY 2023FY 2024FY 2025
Revenue (₹ Cr)32.8846.2761.76
PAT (₹ Cr)2.152.876.04
Total Assets (₹ Cr)23.2334.0151.85
Net Worth (₹ Cr)9.6612.5323.20

Key Growth Metrics

  • Revenue Growth (FY24 to FY25): 33% increase
  • PAT Growth (FY24 to FY25): 110% increase
  • Asset Growth: Consistent expansion year-over-year

Key Performance Indicators (KPIs)

The company’s financial health can be assessed through these critical metrics:

KPIValue
ROCE21.02%
Debt/Equity Ratio0.98
Return on Net Worth33.81%
PAT Margin9.81%
EBITDA Margin15.81%
Price to Book Value5.23

Earnings Per Share Analysis

MetricPre-IPOPost-IPO
EPS (₹)5.794.26
P/E Ratio12.4316.90

IPO Utilization of Funds

The Aakaar Medical Technologies IPO proceeds will be utilized strategically:

S.No.PurposeAmount (₹ Crores)
1Funding Working Capital Requirements20.35
2General Corporate PurposesRemaining Amount

Working Capital Focus

The majority of funds (₹20.35 crores) will be directed toward working capital requirements, indicating the company’s focus on:

  • Inventory management
  • Operational expansion
  • Market penetration
  • Service enhancement

Management and Promoter Details

Promoter Information

  • Key Promoters: Dilip Ramesh Meswani and Bindi Dilip Meswani
  • Pre-IPO Holding: 91.11% of total shareholding
  • Post-IPO Holding: Will be diluted (exact percentage to be calculated)

IPO Intermediaries

RoleCompany
Book Running Lead ManagerIndorient Financial Services Ltd
RegistrarBigshare Services Pvt Ltd
Market MakerAlacrity Securities Ltd

Investment Analysis and Expert Opinion

“AMTL is dealing in a wide range of aesthetics products and related devices. It posted growth in its top and bottom lines for the reported periods. The sudden boost in top and bottom lines in a pre-IPO year i.e., FY25 raise eyebrows and concern over its sustainability going forward.”

Key Investment Considerations

Positive Factors

  • Growing Market: Aesthetic medicine is a rapidly expanding sector in India
  • Diversified Portfolio: Wide range of products and devices
  • Pan-India Presence: Established distribution network
  • Strong Financial Growth: Impressive revenue and profit growth
  • Experienced Management: Decade-long industry experience

Risk Factors

  • Aggressive Pricing: Issue appears aggressively priced based on current valuations
  • Sustainability Concerns: Sudden boost in FY25 financials raises questions
  • SME Listing: Higher volatility compared to main board listings
  • Market Dependence: Reliance on healthcare professional adoption

Competitive Landscape and Market Position

Industry Strengths

Aakaar Medical Technologies has built competitive advantages through:

  1. Experienced Management Team: Leadership with deep industry knowledge
  2. Diversified Customer Base: Serving multiple healthcare specialties
  3. Comprehensive Product Range: Both indigenous and international products
  4. Pan-India Reach: Extensive distribution through consignment partners
  5. Technical Support: 90 trained sales and service engineers

Geographic Presence

The company operates across major Indian states including:

  • North: Delhi, Haryana, Punjab, Chandigarh, Uttarakhand, Uttar Pradesh
  • East: Bihar, West Bengal, Assam
  • West: Gujarat, Maharashtra
  • Central: Madhya Pradesh
  • South: Karnataka, Telangana, Tamil Nadu

Should You Invest in Aakaar Medical Technologies IPO?

Investment Recommendation

Based on comprehensive analysis, here’s our investment perspective:

For Conservative Investors

  • Recommendation: Avoid or Wait
  • Reason: Aggressive pricing and sustainability concerns about recent financial boost

For Moderate Risk Investors

  • Recommendation: Small Allocation Only
  • Reason: Good business model but valuation concerns persist

For Aggressive/High-Risk Investors

  • Recommendation: Moderate Investment
  • Reason: Growth potential in aesthetic medicine sector, but with caution

Key Decision Factors

Before investing in the Aakaar Medical Technologies IPO, consider:

  1. Your Risk Appetite: SME IPOs carry higher volatility
  2. Investment Horizon: Long-term perspective recommended
  3. Portfolio Allocation: Don’t exceed 2-3% of total portfolio
  4. Market Conditions: Current market sentiment and sectoral trends

How to Apply for Aakaar Medical Technologies IPO

Application Process

  1. Through Online Banking: UPI-based applications
  2. Through Broker Platforms: ASBA facility
  3. Bank Branch: Traditional application method

Required Documents

  • PAN Card
  • Demat Account Details
  • Bank Account Information
  • UPI ID (for UPI applications)

Application Tips

  • Bid at Cut-off Price: To avoid rejection due to oversubscription
  • Complete KYC: Ensure all documentation is current
  • Check UPI Limits: Verify daily transaction limits
  • Apply Early: Avoid last-minute technical issues

Open Your Trading Account for IPO Investment

Ready to invest in IPOs? Open your trading and demat account with top brokers:

Recommended Brokers

Related IPO Investment Opportunities

Explore other upcoming IPO opportunities to diversify your investment portfolio:

Frequently Asked Questions (FAQ)

1. What is the Aakaar Medical Technologies IPO price band?
The Aakaar Medical Technologies IPO price band is set at ₹68 to ₹72 per share, with investors recommended to bid at the cut-off price of ₹72.
2. When does the Aakaar Medical Technologies IPO open and close?
The Aakaar Medical Technologies IPO opens on Friday, June 20, 2025, and closes on Tuesday, June 24, 2025.
3. What is the minimum investment required for Aakaar Medical Technologies IPO?
Retail investors need a minimum investment of ₹1,08,800 (1,600 shares at ₹68) or ₹1,15,200 at the cut-off price.
4. When will Aakaar Medical Technologies IPO shares be listed?
The tentative listing date for Aakaar Medical Technologies IPO is Friday, June 27, 2025, on NSE SME.
5. Who are the promoters of Aakaar Medical Technologies?
The promoters are Dilip Ramesh Meswani and Bindi Dilip Meswani, holding 91.11% stake pre-IPO.
6. What is the lot size for Aakaar Medical Technologies IPO?
The lot size is 1,600 shares, and retail investors can apply for only 1 lot.
7. Is Aakaar Medical Technologies IPO a good investment?
Based on analysis, the IPO appears aggressively priced. Well-informed investors with high risk appetite may consider moderate allocation for long-term holding.
8. What is the business of Aakaar Medical Technologies?
The company deals in aesthetic medical products and devices, serving dermatologists, plastic surgeons, and aesthetic physicians across India.

Conclusion

The Aakaar Medical Technologies IPO presents an interesting investment opportunity in India’s growing aesthetic medicine sector. While the company demonstrates strong financial growth and has established a solid market presence, the aggressive pricing and concerns about sustainability of recent financial performance warrant careful consideration.

For investors considering this IPO, remember that SME listings typically experience higher volatility and require a long-term investment perspective. The aesthetic medicine industry is undoubtedly growing, but success will depend on the company’s ability to maintain its growth trajectory and market position.

Key Takeaway: If you decide to invest in the Aakaar Medical Technologies IPO, limit your exposure to a small percentage of your portfolio and be prepared for potential volatility. The company’s fundamentals are decent, but the valuation concerns cannot be ignored.

Are you planning to apply for this IPO? Make sure to complete your research, assess your risk tolerance, and make an informed investment decision. Remember, successful IPO investing requires patience, research, and disciplined portfolio management.

Disclaimer: This analysis is for educational purposes only and should not be considered as financial advice. Please consult with a qualified financial advisor before making investment decisions.
Sharing Is Caring:

Leave a comment